Search

everythinglearnresearchcommunity

for

Search:↓

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

MitoQ helps protect hair cells from damage in hair loss by boosting a protective enzyme.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Ptprq has multiple forms that change during inner ear development.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.